HUMAN T-CELL LEUKEMIA VIRUS TYPE II NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


HUMAN T-CELL LEUKEMIA VIRUS TYPE II

The Human Retroviruses. Gallo RC and Jay G, eds. San Diego, Academic Press, p. 21-33, 1991.. Unique Identifier : AIDSLINE ICDB/92678720
Chen IS; Rosenblatt JD; Dept. of Medicine, Univ. of California, Los Angeles, CA 90024


Abstract: Since its discovery in 1982, human T-cell leukemia virus type II (HTLV-II) has been a virus for which both diseases and its origin have been sought. It is associated with rare forms of human leukemia and may be the cause of hairy cell leukemia. HTLV-II is reviewed, including discovery and epidemiology; evidence for the etiologic role of HTLV-II in chronic T-cell leukemia related to hairy cell leukemia; worldwide recognition of HTLV-II; the role of HTLV-II in human disease; in vitro biological studies of HTLV-II; the molecular genetics of HTLV-II (regulatory genes of HTLV-II, tax gene, and rex gene); and molecular mechanisms of HTLV-II-induced T-cell transformation. In general, insights gained from investigating the molecular genetics of HTLV-II have shown it to be similar to HTLV-I in terms of the overall number and arrangement of viral genes and their function in regard to viral replication. The comparative morphology of HTLV-I and HTLV-II has been extremely informative, both in highlighting important sequence and functional similarities that these viruses share, and in bringing to light differences that ultimately may be relevant to their apparently different pathogenesis. The mechanism of in vitro T-cell transformation by HTLV-II is unknown, but a number of hypotheses have emerged that parallel those proposed for HTLV-I transformation. First, it has been proposed that since the regulatory genes tax and rex are capable of regulating viral gene expression, they also may be able to regulate aberrantly cellular gene expression, resulting in immortalization of infected cells. Another hypothesis derives from observations that HTLV-I and HTLV-II can mitogenically stimulate quiescent T cells to divide in the absence of viral infection. This may involve the HTLV envelope glycoprotein and a receptor on the surface of T cells, which ordinarily may be involved in regulating normal T-cell proliferative responses. Overall, HTLV-II transformation of T cells may resemble the processes of transformation in systems involving oncogenes. Tax, and possibly Rex, and factor at the cell membrane (envelope) may act together to transduce signals, resulting in the final transformed state of T cells. (49 Refs)
Keywords: Cell Transformation, Viral/GENETICS Gene Expression Regulation, Viral/*PHYSIOLOGY Genes, pX/GENETICS/PHYSIOLOGY Human HTLV-II/*GENETICS/PATHOGENICITY HTLV-II Infections/*GENETICS/MICROBIOLOGY Leukemia, Hairy Cell/*GENETICS/MICROBIOLOGY Leukemia, T-Cell, HTLV-II-Associated/*GENETICS/MICROBIOLOGY T-Lymphocytes/MICROBIOLOGY MONOGRAPH REVIEW

KWDcelltransformation,viral/geneticsgeneexpressionregulation,viral/KWDphysiologygenes,px/genetics/physiologyhumanhtlv-ii/KWDgenetics/pathogenicityhtlv-iiinfections/KWDgenetics/microbiologyleukemia,hairycell/KWDgenetics/microbiologyleukemia,t-cell,htlv-ii-associated/KWDgenetics/microbiologyt-lymphocytes/microbiologymonographreview
920330
M9230758


Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .